Patient subgroups | MR-proADM concentration | |
---|---|---|
< 1.27 (nmol/L) | ≥ 1.27 (nmol/L) | |
Subgroup 1: PCT concentration: < 0.25 μg/L (N = 106) | ||
Patients (N) | 65 | 41 |
Antibiotic administration (N, %) | 35 (53.8%) | 34 (82.9%) |
Time to antibiotic administration (min) (median, Q1-Q3) | 127 [45.0–220] | 42 [25.8–116] |
Composite of 28-day mortality and ICU admission (N, %) | 0 (0.0%) | 7 (17.1%) |
Subgroup 2: PCT concentration: ≥ 0.25 and < 0.50 μg/L (N = 24) | ||
Patients (N) | 8 | 16 |
Antibiotic administration (N, %) | 7 (87.5%) | 15 (93.8%) |
Time to antibiotic administration (min) (median, Q1–Q3) | 165 [88–305] | 50 [19.3–186] |
Composite of 28-day mortality and ICU admission (N, %) | 0 (0.0%) | 1 (6.3%) |
Subgroup 3: PCT concentration: ≥ 0.50 μg/L (N = 83) | ||
Patients (N) | 21 | 62 |
Antibiotic administration (N, %) | 15 (71.4%) | 59 (95.2%) |
Time to antibiotic administration (min) (median, Q1–Q3) | 131 [92.8–166] | 45 [26–136.5] |
Composite of 28-day mortality and ICU admission (N, %) | 0 (0.0%) | 15 (24.2%) |